Table 3. Cancer organoid biobanks from various patients
From: Emerging organoid models: leaping forward in cancer research
Cancer types | Cancer organoid types in biobank | Success rate of establishment | Source | Passages | Institution | Refs |
|---|---|---|---|---|---|---|
Metastatic gastrointestinal cancers | ~78 metastatic cancer organoids from 71 patients | 71% | Biopsies | Support | The Institute of Cancer Research, UK | [62] |
CRC | 22 cancer organoids from 27 tumor samples | ~90% | Surgically resected | Support | Royal Netherlands Academy of Arts and Sciences, Holland | [9] |
CRC | 55 cancer organoids from 43 patients | 100% | Biopsies, surgically resected | Support | Keio University, Japan | [42] |
Breast cancers | > 100 cancer organoids from 155 tumors | >80% | Surgically resected | > 20 passages | Royal Netherlands Academy of Arts and Sciences, Holland | [10] |
Pancreatic ductal adenocarcinoma | 114 cancer organoids from 101 patients | 75% | Biopsies, surgically resected, rapid autopsies | ≥ 5 passages | Cold Spring Harbor Laboratory, America | [31] |